Stock BAJAJHCARE BAJAJ HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bajaj HealthCare Limited

Equities

BAJAJHCARE

INE411U01027

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 03:30:51 31/05/2024 pm IST 		5-day change 1st Jan Change
288.3 INR -1.10% Intraday chart for Bajaj HealthCare Limited -4.88% -23.28%
24/05 Bajaj HealthCare Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
24/05 Bajaj HealthCare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 2,760 2,932 2,838 6,508 9,394 8,409
Enterprise Value (EV) 1 3,542 3,661 3,705 8,174 11,942 12,384
P/E ratio 18.2 x 18 x 12.6 x 7.83 x 13.2 x 19.5 x
Yield 0.25% - - 0.37% 0.44% 0.33%
Capitalization / Revenue 0.84 x 0.79 x 0.69 x 0.99 x 1.38 x 1.25 x
EV / Revenue 1.08 x 0.99 x 0.9 x 1.24 x 1.76 x 1.84 x
EV / EBITDA 8.97 x 7.96 x 7.14 x 5.89 x 9.79 x 11.3 x
EV / FCF -56.8 x 105 x -33.6 x -8.74 x -11.3 x -7.25 x
FCF Yield -1.76% 0.95% -2.98% -11.4% -8.82% -13.8%
Price to Book 2.43 x 2.27 x 1.87 x 2.52 x 2.86 x 2.29 x
Nbr of stocks (in thousands) 27,598 27,598 27,598 27,598 27,598 27,598
Reference price 2 100.0 106.2 102.8 235.8 340.4 304.7
Announcement Date 21/08/18 07/09/19 06/10/20 08/09/21 07/09/22 07/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 3,271 3,702 4,107 6,570 6,799 6,733
EBITDA 1 394.9 459.7 518.8 1,387 1,220 1,094
EBIT 1 284.1 345.6 397.5 1,226 1,043 821.9
Operating Margin 8.69% 9.34% 9.68% 18.66% 15.34% 12.21%
Earnings before Tax (EBT) 1 226.8 241.7 324.5 1,188 896.8 582.2
Net income 1 151.9 163.1 225 831.1 713.9 430.2
Net margin 4.64% 4.41% 5.48% 12.65% 10.5% 6.39%
EPS 2 5.502 5.910 8.153 30.11 25.87 15.59
Free Cash Flow 1 -62.32 34.78 -110.3 -935.5 -1,053 -1,708
FCF margin -1.91% 0.94% -2.69% -14.24% -15.49% -25.36%
FCF Conversion (EBITDA) - 7.57% - - - -
FCF Conversion (Net income) - 21.32% - - - -
Dividend per Share 2 0.2500 - - 0.8750 1.500 1.000
Announcement Date 21/08/18 07/09/19 06/10/20 08/09/21 07/09/22 07/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 782 729 868 1,666 2,548 3,975
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.981 x 1.585 x 1.673 x 1.201 x 2.089 x 3.633 x
Free Cash Flow 1 -62.3 34.8 -110 -936 -1,053 -1,708
ROE (net income / shareholders' equity) 14.3% 13.4% 16% 38.1% 24.3% 12.4%
ROA (Net income/ Total Assets) 7.29% 8.07% 8.39% 17.6% 10.5% 6.33%
Assets 1 2,084 2,020 2,683 4,711 6,825 6,795
Book Value Per Share 2 41.20 46.80 54.90 93.60 119.0 133.0
Cash Flow per Share 2 3.000 2.850 1.510 5.160 0.7200 6.420
Capex 1 115 150 227 1,138 793 1,238
Capex / Sales 3.52% 4.05% 5.52% 17.32% 11.66% 18.39%
Announcement Date 21/08/18 07/09/19 06/10/20 08/09/21 07/09/22 07/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
BAJAJ HEALTHCARE LIMITED Stock Bajaj HealthCare Limited
-23.28% 95.34M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
NOVARTIS AG Stock Novartis AG
+9.78% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BAJAJHCARE Stock
  4. Financials Bajaj HealthCare Limited